SEC Form 4 · accession 0001683168-18-000790
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Martin Schmitz
Director
Period of report
May 16, 2017
Accepted (ET)
Mar 28, 2018 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.3075 | May 16, 2017 | A | 250,000 | A | May 16, 2017 | May 14, 2027 | Common Stock | 250,000 | 250,000 | D |
| Employee Stock Option (right to buy)F2 | $0.2303 | Dec 1, 2017 | A | 200,000 | A | Dec 1, 2017 | Nov 30, 2027 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1On May 15, 2017, the Reported Person was granted an option to purchase 250,000 shares of the Issuer's Common Stock, with 50,000 option shares vested as of the date of grant, and the remaining 200,000 shares vesting in twenty-four (24) equal monthly installments measured from May 16, 2017. As of March 26, 2018, 133,333 shares have vested and another 16,666 will vest within 60 days.
- F2On December 1, 2017, the Reported Person was granted an option to purchase 200,000 shares of the Issuer's Common Stock. The option is durational-based, and vests and becomes exercisable in twenty-four (24) successive equal monthly installments, commencing on November 13, 2017. As of March 26, 2018, 33,333 shares have vested and another 16,666 will vest within 60 days, and Dr. Schmitz has not exercised any stock options.